Summary by Futu AI
SAI SANG PHARMACEUTICAL HOLDINGS LIMITED ANNOUNCED A DISCLOSURE OF THE PRIVATIZATION TRANSACTION ON 8 APRIL 2024. In accordance with Rule 22 of the Hong Kong Code of Companies Acquisitions and Mergers, CICC Wealth Investment Limited entered into the relevant securities transactions on 2 April 2024. The transaction includes the sale and purchase of 167,500 shares for a total of $2,977,370.62 and $2,976,729.60, respectively, at a price of $17.7753 per share. CICC Wealth Investment Limited, owned by China International Financial Co., Ltd., and associated with the assignee, is an exempt self-employed trader. The company confirms that all transactions are completed before the end of the morning trading session of the trading day after the transaction initially prompted by customer demand. This disclosure replaces the previous disclosure form dated April 3, 2024.